The Metabolostasis Network and the Cellular Depository of Aggregation‐Prone Metabolites

Abstract

The vital role of metabolites across all branches of life and their involvement in various disorders have been investigated for decades. Many metabolites are poorly soluble in water or in physiological buffers and tend to form supramolecular aggregates. On the other hand, in the cell, they should be preserved in a pool and be readily available for the execution of biochemical functions. We thus propose that a quality‐control network, termed “metabolostasis”, has evolved to regulate the storage and retrieval of aggregation‐prone metabolites. Such a system should control metabolite concentration, subcellular localization, supramolecular arrangement, and interaction in dynamic environments, thus enabling normal cellular physiology, healthy development, and preventing disease onset. The paradigm‐shifting concept of metabolostasis calls for a reevaluation of the traditional view of metabolite storage and dynamics in physiology and pathology and proposes unprecedented directions for therapeutic targets under conditions where metabolostasis is imbalanced.

Self-Assembly of Cysteine into Nanofibrils Precedes Cystine Crystal Formation: Implications for Aggregation Inhibition

“…The fibril-to-crystal interconversion (and vice versa) has been a fascinating but difficult event to capture. Crystal structures of amyloid fibrils have been used for decades to elucidate structures of biologically relevant amyloid fibrils. , In parallel, the fibril-to-crystal transitions are fundamental to materials science in a broader context for applications across medicine to nanotechnology. − …”

Amyloidogenic Propensity of Metabolites in the Uric Acid Pathway and Urea Cycle Critically Impacts the Etiology of Metabolic Disorders

“…Phe fibrils, such as conventional amyloid, could bind to Congo red (CR) and ThT dyes and were cytotoxic to neural cell lines. The study suggested a common etiology between phenylketonuria (PKU), an IEM caused by the accumulation of Phe, and amyloid-associated disorders such as Alzheimer’s and Parkinson’s diseases . This path-breaking research, for the very first time, showed that the study of aggregation of metabolites is of crucial significance as it may be the underlying cause leading to the pathogenesis in IEMs, and hence, a ‘generic amyloid hypothesis’ was proposed.…”